# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001654
Filing Date
2025-08-11
Accepted
2025-08-11 08:15:56
Documents
73
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tmb-20250630x10q.htm iXBRL | 10-Q | 1632265
2 | EX-31.1 | tmb-20250630xex31d1.htm | EX-31.1 | 13930
3 | EX-32.1 | tmb-20250630xex32d1.htm | EX-32.1 | 6868
4 | GRAPHIC | tmb-20250630x10q001.jpg | GRAPHIC | 41117
| Complete submission text file | 0001410578-25-001654.txt |  | 7206239

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | tmb-20250630.xsd | EX-101.SCH | 56619
6 | EX-101.CAL | tmb-20250630_cal.xml | EX-101.CAL | 55255
7 | EX-101.DEF | tmb-20250630_def.xml | EX-101.DEF | 182686
8 | EX-101.LAB | tmb-20250630_lab.xml | EX-101.LAB | 466136
9 | EX-101.PRE | tmb-20250630_pre.xml | EX-101.PRE | 335277
76 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20250630x10q_htm.xml | XML | 1178192

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 251200300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)